By Dr. Priyom Bose, Ph.D. A longitudinal study tracking UK children from toddlerhood to early school age reveals how the timing of pandemic disruption shaped the development and stability of executive ...

Elia projected, "On a projected basis, we anticipate suitable for robust assessment of VYD2311 effectiveness if the clinical performance of VYD2311 matches our modeling and prior experience with COVID ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

Research shows the fall switch to Standard Time causes a deeper mood slump than the spring jump into Daylight Saving Time.

Progyny (PGNY) looks undervalued at 9.3x forward P/E, with strong cash flow, buybacks, and ~60% upside to $28—see the 2026–27 ...

GOP lawmakers from rural areas are pressing for more action to counteract the agriculture industry’s increasingly pessimistic ...

One of the most persistent myths in the nonprofit and social-impact world is that meaningful change requires money first.

Almost a quarter of Florida’s residents who should be screened for this cancer aren't up-to-date with widely accepted ...

"Basically they come in and say, 'we will take every one of you when you get your license,'" a program instructor said.

Promoted by Dr Krishna Ella, the vaccine manufacturer serves both domestic and export markets and remains entirely ...